Effectiveness and Safety Evaluation of Treatment Regimen for Helicobacter pylori Infection Including Levofloxacin: A Prospective, Randomized Controlled Study
- Conditions
- Helicobector pylori
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1.Aged between 18 and 69 years old; 2. Individuals with a positive result in the 13C or 14C breath test, or confirmed as Helicobacter pylori infection through at least two of the following methods: rapid urease test, histopathology, Hp culture, and fecal Hp antigen test; 3. Have not received eradication therapy for Helicobacter pylori in the past; 4. Willing to undergo anti-Hp treatment and sign an informed consent form.
1.Individuals allergic to any investigational drug; 2. Individuals who have undergone partial or total gastrectomy; 3. Individuals with significant organ dysfunction such as respiratory, cardiac, hepatic, renal insufficiency, etc.; 4. Individuals who have used antibiotics or corticosteroids within 4 weeks prior to enrollment, or acid suppressants within 2 weeks prior to enrollment; 5. Pregnant or lactating women; 6. Individuals who are unwilling to sign the informed consent form.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 13C-UBT;
- Secondary Outcome Measures
Name Time Method compliance;